Sponsor:
Genta Incorporated
Code:
NCT01221870
Conditions
Breast Neoplasm
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tesetaxel once every 3 weeks
Tesetaxel once weekly
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Genta Incorporated on 2012-07-24.